Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
XORTX Therapeutics Inc. (XRTX) had Weighted-Average Shares Outstanding (Diluted) of 1.39M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-0.81M |
|
-- |
|
-- |
|
$0.82M |
|
$-0.82M |
|
$0.01M |
|
$-0.81M |
|
$-0.81M |
|
$-0.81M |
|
$-0.81M |
|
$-0.81M |
|
$-0.81M |
|
$-0.82M |
|
$-0.80M |
|
1.39M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
1.39M |
$-0.58 |
|
$-0.58 |
|
| Balance Sheet Financials | |
$0.74M |
|
$0.01M |
|
$1.40M |
|
$2.14M |
|
$0.86M |
|
-- |
|
-- |
|
$0.86M |
|
$1.28M |
|
$1.10M |
|
$1.28M |
|
1.39M |
|
| Cash Flow Statement Financials | |
$-0.50M |
|
$-0.01M |
|
$-0.10M |
|
$0.86M |
|
$0.25M |
|
$-0.61M |
|
$0.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.86 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.50M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-62.97% |
|
-73.62% |
|
-37.69% |
|
-62.97% |
|
$0.92 |
|
$-0.36 |
|
$-0.36 |
|